Kaizen Advisory’s Idexx Laboratories IDXX Stock Holding History

Kaizen Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$46K	Buy	247 +39	+19%	+$8K	0.03%	339
2018 Q3	$52K	Hold	208	–	–	0.03%	326
2018 Q2	$45K	Buy	208 +123	+145%	+$25.3K	0.02%	348
2018 Q1	$16K	Hold	85	–	–	0.02%	374
2017 Q4	$13K	Buy	+85	New	+$13.4K	0.01%	423

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kaizen Advisory's IDXX Position: Q4 2018 in Review

Kaizen Advisory increased its Idexx Laboratories (IDXX) stake by 19% in Q4 2018, buying an estimated $8K and bringing the position to 247 shares worth $46K. The position accounts for 0.03% of the portfolio, ranked #339.

Kaizen Advisory first reported a position in IDXX in Q4 2017 and has held it in 5 quarters since. The position peaked at $52K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

Kaizen Advisory held 247 shares of Idexx Laboratories worth $46K as of Q4 2018.
Kaizen Advisory bought 39 Idexx Laboratories shares in Q4 2018, an estimated $8K.
Idexx Laboratories made up 0.03% of Kaizen Advisory's portfolio in Q4 2018, its #339 holding.
Kaizen Advisory first reported a position in Idexx Laboratories in Q4 2017 and has held it in 5 quarters since.
Kaizen Advisory's Idexx Laboratories position peaked at $52K in Q3 2018.
670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.